{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:52:47Z","timestamp":1774291967475,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation, Singapore Ministry of Health, National Medical Research Council, Precision Health Research, Singapore","award":["MOH-000588-01"],"award-info":[{"award-number":["MOH-000588-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14133-w","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:35:27Z","timestamp":1771940127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FH Genetic Testing in Preventive Cardiology: Unpacking Challenges and Enablers Beyond Cost"],"prefix":"10.1186","volume":"26","author":[{"given":"Chaitanyasre","family":"Lenin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick H. F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe X. H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashna","family":"Nastar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Daccord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Print","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Pek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavintharan","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstadina","family":"Griva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"22","key":"14133_CR1","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","volume":"141","author":"P Hu","year":"2020","unstructured":"Hu P, Dharmayat KI, Stevens CAT, et al. Prevalence of Familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and Meta-Analysis. Circulation. 2020;141(22):1742\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044795.","journal-title":"Circulation"},{"key":"14133_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2018.08.019","volume":"277","author":"T Brett","year":"2018","unstructured":"Brett T, Qureshi N, Gidding S, Watts GF. Screening for Familial hypercholesterolaemia in primary care: time for general practice to play its part. Atherosclerosis. 2018;277:399\u2013406. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.019.","journal-title":"Atherosclerosis"},{"issue":"20","key":"14133_CR3","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of Familial hypercholesterolemia. J Am Coll Cardiol. 2020;75(20):2553\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.057.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"14133_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamacardio.2023.5366","volume":"9","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dron JS, Bellows BK, et al. Familial hypercholesterolemia variant and cardiovascular risk in individuals with elevated cholesterol. JAMA Cardiol. 2024;9(3):263. https:\/\/doi.org\/10.1001\/jamacardio.2023.5366.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"14133_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/medicina60101602","volume":"60","author":"AT Constantin","year":"2024","unstructured":"Constantin AT, Delia C, Ro\u0219u LM, et al. The importance of genetic testing for Familial hypercholesterolemia: A pediatric pilot study. Med Kaunas Lith. 2024;60(10):1602. https:\/\/doi.org\/10.3390\/medicina60101602.","journal-title":"Med Kaunas Lith"},{"issue":"12","key":"14133_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1177\/2047487319829746","volume":"26","author":"S Lee","year":"2019","unstructured":"Lee S, Akioyamen LE, Aljenedil S, Rivi\u00e8re JB, Ruel I, Genest J. Genetic testing for Familial hypercholesterolemia: impact on diagnosis, treatment and cardiovascular risk. Eur J Prev Cardiol. 2019;26(12):1262\u201370. https:\/\/doi.org\/10.1177\/2047487319829746.","journal-title":"Eur J Prev Cardiol"},{"key":"14133_CR7","doi-asserted-by":"publisher","first-page":"860196","DOI":"10.3389\/fcvm.2022.860196","volume":"9","author":"Y Yu","year":"2022","unstructured":"Yu Y, Chen L, Zhang H, et al. Association between Familial hypercholesterolemia and risk of cardiovascular events and death in different cohorts: A Meta-Analysis of 1.1 million subjects. Front Cardiovasc Med. 2022;9:860196. https:\/\/doi.org\/10.3389\/fcvm.2022.860196.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"14133_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jacl.2022.04.005","volume":"16","author":"R Gra\u00e7a","year":"2022","unstructured":"Gra\u00e7a R, Alves AC, Zimon M, Pepperkok R, Bourbon M. Functional profiling of LDLR variants: important evidence for variant classification: functional profiling of LDLR variants. J Clin Lipidol. 2022;16(4):516\u201324. https:\/\/doi.org\/10.1016\/j.jacl.2022.04.005.","journal-title":"J Clin Lipidol"},{"key":"14133_CR9","unstructured":"Ison HE, Clarke SL, Knowles JW. Familial Hypercholesterolemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews\u00ae. University of Washington, Seattle; 1993. Accessed February 28, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK174884\/."},{"issue":"2","key":"14133_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2013.09.019","volume":"231","author":"P Brice","year":"2013","unstructured":"Brice P, Burton H, Edwards CW, Humphries SE, Aitman TJ. Familial hypercholesterolaemia: A pressing issue for European health care. Atherosclerosis. 2013;231(2):223\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.019.","journal-title":"Atherosclerosis"},{"issue":"1","key":"14133_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/CS20140755","volume":"129","author":"MM Page","year":"2015","unstructured":"Page MM, Stefanutti C, Sniderman A, Watts GF. Recent advances in the Understanding and care of Familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin\/kexin type 9. Clin Sci. 2015;129(1):63\u201379. https:\/\/doi.org\/10.1042\/CS20140755.","journal-title":"Clin Sci"},{"key":"14133_CR12","unstructured":"Launch of national familial hypercholesterolaemia genetic testing programme. Ministry of Health. Accessed December 27. 2025. https:\/\/www.moh.gov.sg\/newsroom\/launch-of-national-familial-hypercholesterolaemia-genetic-testing-programme-\/."},{"issue":"2","key":"14133_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jacl.2020.02.001","volume":"14","author":"SS Gidding","year":"2020","unstructured":"Gidding SS, Sheldon A, Neben CL, et al. Patient acceptance of genetic testing for Familial hypercholesterolemia in the CASCADE FH registry. J Clin Lipidol. 2020;14(2):218\u2013218. https:\/\/doi.org\/10.1016\/j.jacl.2020.02.001.","journal-title":"J Clin Lipidol"},{"key":"14133_CR14","doi-asserted-by":"publisher","unstructured":"Lenin C, Lim PXH, Nastar A, et al. Facilitators and barriers to uptake of genetic and cascade testing in Familial hypercholesterolemia: a systematic review. Int J Behav Med Published Online April. 2025;8. https:\/\/doi.org\/10.1007\/s12529-025-10357-y.","DOI":"10.1007\/s12529-025-10357-y"},{"issue":"1","key":"14133_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jpm9010009","volume":"9","author":"RM Hendricks-Sturrup","year":"2019","unstructured":"Hendricks-Sturrup RM, Lu CY. Understanding implementation challenges to genetic testing for Familial hypercholesterolemia in the united States. J Pers Med. 2019;9(1):9. https:\/\/doi.org\/10.3390\/jpm9010009.","journal-title":"J Pers Med"},{"key":"14133_CR16","unstructured":"Familial Hypercholesterolemia (FH) \u2013 For Clinicians | Singapore Heart Foundation. Accessed January 15. 2026. https:\/\/www.myheart.org.sg\/health\/risk-factors\/familial-hypercholesterolemia\/fh-for-clinicians\/."},{"key":"14133_CR17","doi-asserted-by":"publisher","unstructured":"van El CG, Baccolini V, Piko P, Cornel MC. Stakeholder views on active cascade screening for Familial hypercholesterolemia. Healthc Basel Switz. 2018;6(3). https:\/\/doi.org\/10.3390\/healthcare6030108.","DOI":"10.3390\/healthcare6030108"},{"issue":"3","key":"14133_CR18","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.jacl.2022.05.007","volume":"16","author":"E Calvo","year":"2022","unstructured":"Calvo E, Walters N, Brangan A, et al. Barriers and facilitators to Identification, cascade Testing, and treatment for Familial hypercholesterolemia: A scoping Review\u2026 National lipid association scientific Sessions, June 2\u20136, 2022, Scottsdale, Arizona. J Clin Lipidol. 2022;16(3):e35\u20136. https:\/\/doi.org\/10.1016\/j.jacl.2022.05.007.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"14133_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"14133_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","volume":"24","author":"V Braun","year":"2023","unstructured":"Braun V, Clarke V. Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher. Int J Transgender Health. 2023;24(1):1\u20136. https:\/\/doi.org\/10.1080\/26895269.2022.2129597.","journal-title":"Int J Transgender Health"},{"key":"14133_CR21","doi-asserted-by":"publisher","unstructured":"Hendricks-Sturrup RM, Clark-LoCascio J, Lu CEY. A global review on the utility of genetic testing for Familial hypercholesterolemia. J Pers Med. 2020;10(2). https:\/\/doi.org\/10.3390\/jpm10020023.","DOI":"10.3390\/jpm10020023"},{"issue":"6","key":"14133_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ahj.2014.09.001","volume":"168","author":"Reducing the burden of","year":"2014","unstructured":"Reducing the burden of. Disease and death from Familial hypercholesterolemia: A call to action. Am Heart J. 2014;168(6):807\u201311. https:\/\/doi.org\/10.1016\/j.ahj.2014.09.001.","journal-title":"Am Heart J"},{"issue":"3","key":"14133_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajmg.a.30102","volume":"128A","author":"T Marteau","year":"2004","unstructured":"Marteau T, Senior V, Humphries SE, et al. Psychological impact of genetic testing for Familial hypercholesterolemia within a previously aware population: A randomized controlled trial. Am J Med Genet. 2004;128A(3):285\u201393. https:\/\/doi.org\/10.1002\/ajmg.a.30102.","journal-title":"Am J Med Genet"},{"issue":"720","key":"14133_CR24","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.3399\/BJGP.2021.0558","volume":"72","author":"L Silva","year":"2022","unstructured":"Silva L, Condon L, Qureshi N, Dutton B, Weng S, Kai J. Introducing genetic testing with case finding for Familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience. Br J Gen Pract. 2022;72(720):e519\u201327. https:\/\/doi.org\/10.3399\/BJGP.2021.0558.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"14133_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10897-005-9001-8","volume":"15","author":"HW van den Nieuwenhoff","year":"2006","unstructured":"van den Nieuwenhoff HW, Mesters I, Nellissen JJ, Stalenhoef AF, de Vries NK. The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol. J Genet Couns. 2006;15(1):29\u201340. https:\/\/doi.org\/10.1007\/s10897-005-9001-8.","journal-title":"J Genet Couns"},{"issue":"4","key":"14133_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1467-9566.2012.01510.x","volume":"35","author":"N Jenkins","year":"2013","unstructured":"Jenkins N, Lawton J, Douglas M, Hallowell N. Inter-embodiment and the experience of genetic testing for Familial hypercholesterolaemia. Sociol Health Illn. 2013;35(4):529\u201343. https:\/\/doi.org\/10.1111\/j.1467-9566.2012.01510.x.","journal-title":"Sociol Health Illn"},{"issue":"1","key":"14133_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12529-014-9402-x","volume":"22","author":"S Hardcastle","year":"2015","unstructured":"Hardcastle S, Legge E, Laundy C, et al. Patients\u2019 perceptions and experiences of Familial Hypercholesterolemia, cascade genetic screening and treatment. Int J Behav Med. 2015;22(1):92\u2013100. https:\/\/doi.org\/10.1007\/s12529-014-9402-x.","journal-title":"Int J Behav Med"},{"issue":"5","key":"14133_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000121398","volume":"11","author":"K Weiner","year":"2008","unstructured":"Weiner K, Durrington PN. Patients\u2019 Understandings and experiences of Familial hypercholesterolemia. Public Health Genomics. 2008;11(5):273\u201382. https:\/\/doi.org\/10.1159\/000121398.","journal-title":"Public Health Genomics"},{"issue":"1\u20132","key":"14133_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000501463","volume":"22","author":"FL Bowman","year":"2019","unstructured":"Bowman FL, Molster CM, Lister KJ, et al. Identifying perceptions and preferences of the general public concerning universal screening of children for Familial hypercholesterolaemia. Public Health Genomics. 2019;22(1\u20132):25\u201335. https:\/\/doi.org\/10.1159\/000501463.","journal-title":"Public Health Genomics"},{"issue":"5","key":"14133_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/13548506.2011.644246","volume":"17","author":"L Claassen","year":"2012","unstructured":"Claassen L, Henneman L, van der Weijden T, Marteau TM, Timmermans DR. Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition. Psychol Health Med. 2012;17(5):511\u201321.","journal-title":"Psychol Health Med"},{"issue":"2","key":"14133_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10689-023-00356-x","volume":"23","author":"LA Grutters","year":"2024","unstructured":"Grutters LA, Christiaans I. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review. Fam Cancer. 2024;23(2):155\u201364. https:\/\/doi.org\/10.1007\/s10689-023-00356-x.","journal-title":"Fam Cancer"},{"key":"14133_CR32","doi-asserted-by":"publisher","unstructured":"Farwati M, Kumbamu A, Kochan D, Kullo I. A patient decision aid for Familial hypercholesterolemia based on patient and provider feedback. J Am Coll Cardiol. 2018;71(11 Supplement 1). https:\/\/doi.org\/10.1016\/S0735-1097%2818%2933194-2.","DOI":"10.1016\/S0735-1097%2818%2933194-2"},{"issue":"1","key":"14133_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12687-016-0286-0","volume":"8","author":"N Hallowell","year":"2017","unstructured":"Hallowell N, Jenkins N, Douglas M, et al. A qualitative study of patients\u2019 perceptions of the value of molecular diagnosis for Familial hypercholesterolemia (FH). J Community Genet. 2017;8(1):45\u201352. https:\/\/doi.org\/10.1007\/s12687-016-0286-0.","journal-title":"J Community Genet"},{"issue":"3","key":"14133_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41431-023-01373-1","volume":"32","author":"J Tiller","year":"2024","unstructured":"Tiller J, Bakshi A, Dowling G, et al. Community concerns about genetic discrimination in life insurance persist in australia: A survey of consumers offered genetic testing. Eur J Hum Genet. 2024;32(3):286\u201394. https:\/\/doi.org\/10.1038\/s41431-023-01373-1.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"14133_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jgc4.1329","volume":"30","author":"CM Studwell","year":"2021","unstructured":"Studwell CM, Kelley EG, Sinsheimer JS, et al. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice. J Genet Couns. 2021;30(2):439\u201347. https:\/\/doi.org\/10.1002\/jgc4.1329.","journal-title":"J Genet Couns"},{"key":"14133_CR36","doi-asserted-by":"crossref","unstructured":"Taket A, McKay FH. Health equity and human rights. Health Equity, social justice and human rights. 2nd ed. Routledge; 2020.","DOI":"10.4324\/9780429299841"},{"key":"14133_CR37","doi-asserted-by":"crossref","unstructured":"Coen E, Del Fiol G, Kaphingst KA, et al. Chatbot for the return of positive genetic screening results for hereditary cancer syndromes: a prompt engineering Study. Res Sq. Published Online August. 2024;29. rs.3.rs-4986527.","DOI":"10.2196\/preprints.65848"},{"issue":"9","key":"14133_CR38","doi-asserted-by":"publisher","first-page":"e090084","DOI":"10.1136\/bmjopen-2024-090084","volume":"14","author":"G D\u2019Amours","year":"2024","unstructured":"D\u2019Amours G, Clausen M, Luca S, et al. Genetics navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations. BMJ Open. 2024;14(9):e090084. https:\/\/doi.org\/10.1136\/bmjopen-2024-090084.","journal-title":"BMJ Open"},{"issue":"6","key":"14133_CR39","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.pec.2021.09.027","volume":"105","author":"E Siglen","year":"2022","unstructured":"Siglen E, Vetti HH, Lunde ABF, et al. Ask Rosa \u2013 The making of a digital genetic conversation tool, a chatbot, about hereditary breast and ovarian cancer. Patient Educ Couns. 2022;105(6):1488\u201394. https:\/\/doi.org\/10.1016\/j.pec.2021.09.027.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"14133_CR40","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.gim.2024.101122","volume":"26","author":"W Lee","year":"2024","unstructured":"Lee W, Hirjikaka D, Grewal S, et al. Genetics providers\u2019 perspectives on the use of digital tools in clinical practice. Genet Med Off J Am Coll Med Genet. 2024;26(6):101122. https:\/\/doi.org\/10.1016\/j.gim.2024.101122.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"5","key":"14133_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jgc4.1592","volume":"31","author":"T Schmidlen","year":"2022","unstructured":"Schmidlen T, Jones CL, Campbell-Salome G, McCormick CZ, Vanenkevort E, Sturm AC. Use of a chatbot to increase uptake of cascade genetic testing. J Genet Couns. 2022;31(5):1219\u201330. https:\/\/doi.org\/10.1002\/jgc4.1592.","journal-title":"J Genet Couns"},{"issue":"9","key":"14133_CR42","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.gim.2022.05.012","volume":"24","author":"A Polanski","year":"2022","unstructured":"Polanski A, Wolin E, Kocher M, Zierhut H. A scoping review of interventions increasing screening and diagnosis of Familial hypercholesterolemia. Genet Med. 2022;24(9):1791\u2013802. https:\/\/doi.org\/10.1016\/j.gim.2022.05.012.","journal-title":"Genet Med"},{"issue":"6","key":"14133_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","volume":"72","author":"AC Sturm","year":"2018","unstructured":"Sturm AC, Knowles JW, Gidding SS, et al. Clinical genetic testing for Familial hypercholesterolemia. J Am Coll Cardiol. 2018;72(6):662\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.044.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"14133_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s40142-014-0036-8","volume":"2","author":"AC Sturm","year":"2014","unstructured":"Sturm AC. The role of genetic counselors for patients with Familial hypercholesterolemia. Curr Genet Med Rep. 2014;2(2):68\u201374. https:\/\/doi.org\/10.1007\/s40142-014-0036-8.","journal-title":"Curr Genet Med Rep"},{"issue":"Supplement 1","key":"14133_CR45","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.hlc.2022.04.039","volume":"31","author":"A Rutstein","year":"2022","unstructured":"Rutstein A, Baldini M, Morris N, et al. Embedding genetic counselling into cardiology clinics: case studies from a Queensland cardiology genomics service. Heart Lung Circ. 2022;31(Supplement 1):S18. https:\/\/doi.org\/10.1016\/j.hlc.2022.04.039.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"14133_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jgc4.1466","volume":"31","author":"E Baldry","year":"2022","unstructured":"Baldry E, Redlinger-Grosse K, MacFarlane I, et al. Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening. J Genet Couns. 2022;31(1):164\u201375. https:\/\/doi.org\/10.1002\/jgc4.1466.","journal-title":"J Genet Couns"},{"issue":"12","key":"14133_CR47","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41431-020-00725-5","volume":"28","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28(12):1631\u201344. https:\/\/doi.org\/10.1038\/s41431-020-00725-5.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"14133_CR48","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/jpm12081228","volume":"12","author":"CG Allen","year":"2022","unstructured":"Allen CG, Lenert L, Hunt K, et al. Lessons learned from the pilot phase of a Population-Wide genomic screening program: Building the base to reach a diverse cohort of 100,000 participants. J Pers Med. 2022;12(8):1228. https:\/\/doi.org\/10.3390\/jpm12081228.","journal-title":"J Pers Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14133-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:56:33Z","timestamp":1774288593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14133"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14133-w","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Domain Specific Review Board (DSRB), under the F2 Domain (DSRB 2023\/00983), which approves studies in accordance with the Declaration of Helsinki. This is the designated ethics committee for medical and clinical research in Singapore, as participants were recruited from records at general hospitals offering familial hypercholesterolemia (FH) testing. Approval from the NTU Institutional Review Board (IRB) was also obtained to include participants recruited from the community. All participants signed consent forms indicating their consent to participate in the interviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}